Biome Grow (FRA:6OTA) OCF Margin %: 0.00% (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biome Grow OCF Margin %?

Biome Grow FRA:6OTA OCF Margin % is 0.00% as of Sep. 2023.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Biome Grow's Cash Flow from Operations for the three months ended in Sep. 2023 was €-0.01 Mil. Biome Grow's Revenue for the three months ended in Sep. 2023 was €0.00 Mil. Therefore, Biome Grow's OCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Biome Grow's current OCF Yield % is 0.00%.

The historical rank and industry rank for Biome Grow's OCF Margin % or its related term are showing as below:


FRA:6OTA's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 10.025
* Ranked among companies with meaningful OCF Margin % only.

Biome Grow OCF Margin % Related Terms

Biome Grow OCF Margin % Historical Data

* Premium members only.

The historical data trend for Biome Grow's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biome Grow OCF Margin % Chart

Biome Grow Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biome Grow Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biome Grow OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Biome Grow's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-0.516/0
= %

Biome Grow's OCF Margin for the quarter that ended in Sep. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.011/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Biome Grow (FRA:6OTA) has a OCF Margin % of 0.00% as of Sep. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biome Grow and its competitors.
Is Biome Grow's OCF Margin % too high?
Biome Grow's current OCF Margin % is 0.00%.
How does Biome Grow's OCF Margin % compare to ZTS?
Biome Grow's OCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 10.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.03, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biome Grow and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biome Grow's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Grow stock overvalued right now?
Biome Grow (FRA:6OTA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Biome Grow (FRA:6OTA), the current OCF Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biome Grow Business Description

Address 480 University Avenue, Suite 1401, Toronto, ON, CAN, M5G 1V2
Biome Grow Inc is a Canada-based company engaged in medical and recreational cannabis businesses.